Zoetis Inc. (NYSE:ZTS) Shares Bought by Lyell Wealth Management LP

Lyell Wealth Management LP lifted its position in shares of Zoetis Inc. (NYSE:ZTS) by 1.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 67,052 shares of the company’s stock after purchasing an additional 912 shares during the quarter. Zoetis accounts for approximately 1.2% of Lyell Wealth Management LP’s portfolio, making the stock its 25th largest holding. Lyell Wealth Management LP’s holdings in Zoetis were worth $13,101,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Elwood & Goetz Wealth Advisory Group LLC acquired a new stake in shares of Zoetis during the 3rd quarter valued at about $248,000. Trueblood Wealth Management LLC lifted its stake in Zoetis by 14.7% in the 3rd quarter. Trueblood Wealth Management LLC now owns 4,127 shares of the company’s stock valued at $806,000 after buying an additional 530 shares in the last quarter. Lake Street Advisors Group LLC boosted its holdings in Zoetis by 24.4% in the 3rd quarter. Lake Street Advisors Group LLC now owns 10,845 shares of the company’s stock worth $2,119,000 after buying an additional 2,125 shares during the last quarter. Schmidt P J Investment Management Inc. increased its stake in Zoetis by 5.6% during the 3rd quarter. Schmidt P J Investment Management Inc. now owns 1,422 shares of the company’s stock worth $278,000 after buying an additional 75 shares in the last quarter. Finally, Nicholson Wealth Management Group LLC acquired a new position in shares of Zoetis during the third quarter valued at approximately $648,000. 92.80% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently commented on ZTS shares. Stifel Nicolaus increased their price objective on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. Argus raised shares of Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. Piper Sandler boosted their target price on Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th. JPMorgan Chase & Co. lifted their price objective on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Finally, BTIG Research upped their target price on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a report on Monday, August 12th. Ten research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Buy” and an average target price of $221.44.

Zoetis Stock Performance

Shares of ZTS stock opened at $180.01 on Friday. Zoetis Inc. has a one year low of $144.80 and a one year high of $201.92. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45. The firm’s 50 day moving average price is $189.18 and its 200-day moving average price is $177.61. The firm has a market cap of $82.14 billion, a P/E ratio of 34.68, a P/E/G ratio of 2.94 and a beta of 0.89.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.07. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. The business had revenue of $2.36 billion during the quarter, compared to analysts’ expectations of $2.31 billion. During the same period in the previous year, the firm posted $1.41 earnings per share. The company’s revenue was up 8.3% on a year-over-year basis. As a group, equities research analysts predict that Zoetis Inc. will post 5.83 EPS for the current year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be paid a dividend of $0.432 per share. This represents a $1.73 annualized dividend and a yield of 0.96%. The ex-dividend date of this dividend is Thursday, October 31st. Zoetis’s payout ratio is currently 33.14%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.